title: Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.
abstract: The synthesis of aryldiazonium and arylazido derivatives of carfentanil, etonitazene, and naltrexone and of a triazaspirodecane derivative is described. The chemical stability and the spectral characteristics of these compounds were verified, and their binding affinity constants for the different opioid receptor classes were determined, in the absence of light, from competition experiments. With the exception of the naltrexyl derivatives, which remained nonselective, all compounds tested displayed a pronounced mu-binding selectivity with mu/delta and mu/kappa ratios ranging from 12 to 1000. After irradiation, only the arylazido probes led to an irreversible mu-binding-site inactivation. This inactivation fulfilled the criteria for photoaffinity labeling such as protection against inactivation by other opiate ligands and absence of an effect of scavengers on the extent of the inactivation. Most of the photoactivatable probes formed long-lasting reversible complexes with the opioid binding sites: an efficient dissociation procedure was thus required to discriminate between pseudoirreversible and covalent complexes. The marked differences in labeling efficacy between aryldiazonium salts and their corresponding arylazido derivatives are discussed.
authors.affiliation: Laboratoire de Chimie Bio-Organique associé au CNRS (URA 1386), Université Louis Pasteur, Strasbourg, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Galzi
authors.forename: A
authors.initials: A
authors.lastname: Mejean
authors.forename: B
authors.initials: B
authors.lastname: Ilien
authors.forename: C
authors.initials: C
authors.lastname: Mollereau
authors.forename: J C
authors.initials: JC
authors.lastname: Meunier
authors.forename: M
authors.initials: M
authors.lastname: Goeldner
authors.forename: C
authors.initials: C
authors.lastname: Hirth
mesh_terms: D000345:Affinity Labels / Q000138:chemical synthesis*; D000818:Animals; D001386:Azides / Q000138:chemical synthesis* / Q000378:metabolism; D001391:Azo Compounds / Q000138:chemical synthesis* / Q000378:metabolism; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D009294:Narcotics / Q000138:chemical synthesis* / Q000378:metabolism; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D017450:Receptors, Opioid, mu; D013329:Structure-Activity Relationship
chemical_list: D000345:Affinity Labels; D001386:Azides; D001391:Azo Compounds; D009294:Narcotics; D011957:Receptors, Opioid; D017450:Receptors, Opioid, mu